Global CAR T-Cell Therapy Market Size By Targeted Antigen (CD 19, HER1), By Therapeutic Application (Acute Lymphocytic Leukemia, Colorectal Cancer), By Geographic Scope And Forecast

CAR T-Cell Therapy Market Size And Forecast

CAR T-Cell Therapy Market size was valued at USD 589.99 Million in 2020 and is projected to reach USD 51408.40 Million by 2028, growing at a CAGR of 63.82% from 2021 to 2028.

The global CAR T-Cell Therapy Market is predicted to develop in response to the rising incidence of cancer and the rising number of patients who have failed to respond to alternative treatments. The Global CAR T-Cell Therapy Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global CAR T-Cell Therapy Market Definition

Chimeric antigen receptor (CAR) T-cell therapy is a sort of immunotherapy that alters the immune system of a cancer patient to make it more effective at identifying and destroying cancer cells. Cancer cells are known to hide from the immune system, but scientists have been able to improve T cells’ ability to locate and kill cancer cells using CAR T therapy. The immune system of a human is immensely complicated and involves multiple distinct types of cells and processes throughout the body. A lymphocyte, a type of white blood cell that acts to combat infection, is one of these cells. Lymphocytes come in a variety of shapes and sizes, one of which is known as a T cell. Furthermore, T cells are used in CAR T-cell therapy since they are generally responsible for destroying malignant cells and virus-infected cells.

Moreover, in CAR-T treatment, doctors take a patient’s immune cells, modify them in the lab, and give them the ability to recognize and kill cancer cells before infusing them back into the patient. Therefore, the injected cells multiply in the body and act as living medications. CAR-T cells are genetically modified cell receptors that are connected to cancer patients’ T-cells and injected into the bloodstream, prompting the immune system to activate and kill cancer-causing cells in the body. Although various tumors have distinct antigens, each CAR T-cell is programmed to recognize specific cancer antigens. The FDA has approved this medicine for the treatment of cancer. As a result, manufacturers have a significant chance to invest in and profit from artificial antibody receptor CAR T-cell therapy for cancer cell targeting.

Global CAR T-Cell Therapy Market Overview

The global CAR T-Cell Therapy Market is predicted to develop in response to the rising incidence of cancer and the rising number of patients who have failed to respond to alternative treatments. Additionally, rising public awareness about healthcare and wellbeing, changing illness patterns, government backing, and increasing volumes of T-Cell therapy applications in various cancer research institutions are likely to fuel the market’s expansion. Furthermore, the industry is being fueled by rising government programs aimed at enhancing healthcare infrastructure and encouraging cancer-cell treatment research.

However, concerns about the cell therapy’s negative effects and other neurological issues are predicted to impede the market growth. Also, the lack of demand for therapy is one of the key constraints that industry players confront. The target audience is excessively strict and only understands native treatment methods. Furthermore, the accompanying treatment cost is very high, which does not sit well with the people because they come from various income categories and have diverse spending capacities. The global CAR T-Cell Therapy Market trends and operations are likely to pose major restraints for the market if costs and prices are not reduced, preventing the market from growing as predicted by industry leaders and CAR T-Cell Therapy Market experts during the forecast period.

Global CAR T-Cell Therapy Market Segmentation Analysis

The Global CAR T-Cell Therapy Market is Segmented on the basis of  Targeted Antigen, Therapeutic Application, And Geography.

CAR T-Cell Therapy Market, By Targeted Antigen

• CD 19• HER1• BCMA• CD33• Others

Based on Targeted Antigen, the market is segmented into CD 19, HER1, BCMA, CD33, and Others. The CD19 holds a big market share. Because CD19 expression on normal cells is limited to those of the B-cell lineage, it makes an appealing target for cancer therapy. Also, BCMA was growing with the largest CAGR.

CAR T-Cell Therapy Market, By Therapeutic Application

• Acute Lymphocytic Leukemia• Colorectal Cancer• Chronic Lymphocytic Leukemia• Hepatocellular Carcinoma• Others

Based on Therapeutic Application, the market is segmented into Acute Lymphocytic Leukemia, Colorectal Cancer, Chronic Lymphocytic Leukemia, Hepatocellular Carcinoma, and Others. The Acute Lymphocytic Leukemia segment holds the big market share. Leukemias are malignancies that begin in cells that would typically develop into various blood cell types. Leukemia usually begins in the early stages of white blood cells; however, it can also begin in other types of blood cells.

CAR T-Cell Therapy Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, the Global CAR T-Cell Therapy Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The North American region is expected to witness the highest CAGR during the forecast period. This is attributable to an increase in the number of life sciences businesses working on the research and commercialization of CAR T-cells in this region, as well as improvements in quality control systems.

Key Players

The “Global CAR T-Cell Therapy Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as CARsgen Therapeutics, Ltd., Novartis International AG, Pfizer, Inc., Kite Pharma, Inc., Legend Biotech, Juno Therapeutics, Aurora Biopharma Inc., Bluebird Bio, Inc., Mustang Bio, Inc., and Sorrento Therapeutics Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In February 2022, CARsgen announced that they open a new U.S. cGMP Facility for CAR-T production. CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.

• In December 2021, Novartis announced to launch T-Charge, a next-generation CAR-T platform with first-in-human data at ASH 2021.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.